Top Story

Shorter ADT regimen improved quality of life among men with high-risk prostate cancer

September 16, 2014

Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved testosterone recovery than those who underwent radiotherapy plus 36 months of androgen deprivation, according to results of a randomized phase 3 study presented at the ASTRO Annual Meeting.

“Those who recover normal testosterone value have better quality of life,” Abdenour Nabid, MD, radiation oncologist at Centre Hospitalier Universitaire de Sherbrooke and associate professor at the University of Sherbrooke in Quebec, Canada, said during a press conference. “A higher proportion of patients [assigned 18 months of androgen deprivation therapy] recovered normal testosterone value, and they did so in a much shorter time. This was done without any apparent detriment to long-term outcomes.”

Report: Commitment to NIH, NCI funding only 'viable path' for continued success in cancer research

September 16, 2014
The scientific community’s continued quest to prevent and cure cancer has reached a crossroads, according to a report released today by the American Association…
Meeting News Coverage

High-dose radiation plus long-term ADT extended survival in prostate cancer

September 15, 2014
Men with intermediate or high-risk prostate cancer who underwent high-dose radiation therapy followed by a longer duration of androgen deprivation therapy demonstrated…
In the JournalsPerspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United Kingdom.More than…
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »

Filter By:

figure Meeting News Coverage

Shorter ADT regimen improved quality of life among men with high-risk prostate cancer

September 16, 2014
Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved…

Report: Commitment to NIH, NCI funding only 'viable path' for continued success in cancer research

September 16, 2014
The scientific community’s continued quest to prevent and cure cancer has reached a crossroads, according to a report released today by the…
Meeting News Coverage

High-dose radiation plus long-term ADT extended survival in prostate cancer

September 15, 2014
Men with intermediate or high-risk prostate cancer who underwent high-dose radiation therapy followed by a longer duration of androgen deprivation…
In the Journals Perspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United…
In the Journals Perspective

Smoking habits persisted among cancer survivors

August 6, 2014
Nearly one-tenth of cancer survivors continued to smoke 9 years after diagnosis, according to results of a population-based study.Among that group…
figure Editorial Publication Exclusive

Hazard ratios are potential biohazards

HemOnc Today, July 25, 2014
Derek Raghavan, MD, PhD
The 2014 ASCO Annual Meeting was a paradigm-shifting aggregation of progress in clinical cancer research and practice.
figure Cover Story Publication Exclusive

Liquid biopsies provide extensive information, but technology carries ‘potential for overuse’

HemOnc Today, July 25, 2014
Researchers have known for decades that tumors shed cells and DNA into the bloodstream.
In the Journals

Neutrophil-to-lymphocyte ratio improved accuracy of prognostic score for castration-resistant prostate cancer

July 16, 2014
A prognostic score that included neutrophil-to-lymphocyte ratio accurately predicted OS for men with metastatic castration-resistant prostate cancer…
In the Journals Perspective

Testicular germ cell tumor incidence increased in Hispanic adolescents, young adults

July 14, 2014
The incidence of testicular germ cell tumors increased significantly in recent years among Hispanic adolescents and young adults, yet this trend was…
In the Journals Perspective

Sarcopenia increased risk for mortality after radical cystectomy for bladder cancer

July 2, 2014
Sarcopenia independently predicted shorter cancer-specific survival and OS among patients who underwent radical cystectomy for urothelial cancer of…
More Headlines »